董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Donald Hunter | 男 | Chairman of the Board and Director | 69 | 7.60万美元 | 33.00 | 2026-01-21 |
| Bruce Linton | 男 | Independent Director | 60 | 未披露 | 未持股 | 2026-01-21 |
| William Levy | 男 | Independent Director | 45 | 未披露 | 未持股 | 2026-01-21 |
| Jonathan Hue Fay Ip | -- | Director | -- | 未披露 | 未持股 | 2026-01-21 |
| Michael C. Howe | 男 | Independent Director | 74 | 未披露 | 32.00 | 2026-01-21 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Benjamin Isenberg | 男 | Chief Investment Officer | 28 | 未披露 | 未持股 | 2026-01-21 |
| Vanessa Guzman Clark | -- | Chief Financial Officer | 46 | 未披露 | 8.15 | 2026-01-21 |
董事简历
中英对照 | 中文 | 英文- Donald Hunter
-
Donald Hunter自2021年8月与KushCo合并以来一直担任董事，此前曾于2018年2月至合并完成期间担任KushCo的董事。自2007年以来，亨特一直担任Donald Hunter，LLC的负责人，这是一家协助私募股权公司和企业家在2021年之前提升其技术公司价值的咨询机构。他此前曾于2000年至2006年在Harbor Global Company Limited（一家公开上市的投资管理、自然资源和房地产公司）担任首席运营官和首席财务官，并于1988年至2000年在The Pioneer Group，Inc.担任高级管理人员，负责国际初创公司。Hunter的职业生涯始于通用电气公司，曾是该公司审计部门的一员，也是该公司财务管理培训计划的毕业生。自2013年起，Hunter先生担任在纽约证券交易所上市的频率和频谱控制工程与制造公司The LGL Group，Inc.（“LGL”）的董事会成员，还担任LGL审计委员会主席及其提名委员会成员，之前曾在其薪酬委员会任职至2022年12月。此前，Hunter先生于2014年3月至2016年3月期间担任纳斯达克上市的特种制药公司瞻博制药的董事会成员、审计委员会主席和提名委员会成员，并于2014年6月至2015年6月期间担任LICT Corporation的董事会成员，LICT Corporation是一家在电信和多媒体领域拥有子公司的控股公司。亨特先生符合SEC适用规则下的金融专家资格，是美国全国公司董事协会的活跃成员。他以优异成绩获得理学学士学位，并获得波士顿大学荣誉MBA学位。亨特先生超过25年的上市公司经验和公司治理、SEC报告、内部控制、国际运营和并购事务方面的知识促使他被任命为董事。
Donald Hunter has served as a director since the merger with KhCo in Augt 2021 and previoly served as a director of KhCo from February 2018 until the closing of the merger. Mr. Hunter served as principal at Donald Hunter, LLC, a consulting practice that assists private equity firms and entrepreneurs to enhance the value of their technology companies from 2007 to 2021. He previoly served as Chief Operating Officer and Chief Financial Officer of Harbor Global Company Limited, a publicly traded investment management, natural resces, and real estate company from 2000 through 2006, and as a senior executive at The Pioneer Group, Inc. from 1988 through 2000, with responsibility for international start up companies. Mr. Hunter began his career at the General Electric Company, where he was a member of the corporate audit staff and a graduate of its Financial Management Training Program. From 2013 to 2022, Mr. Hunter served as a member of the board of directors of The LGL Group, Inc. ("LGL"), an NYSE listed frequency and spectrum control engineering and manufacturing company, and also serves as the Chairman of the LGL Audit Committee and a member of its Nominating Committee, and formerly served on its Compensation Committee. Previoly, Mr. Hunter served as a member of the board of directors, Chairman of the Audit Committee and member of the Nominating Committee of Juniper Pharmaceuticals, a Nasdaq listed specialty pharmaceuticals company, from March 2014 through March 2016, and a member of the board of directors of LICT Corporation, a holding company with subsidiaries in telecommunications and multimedia, from June 2014 through June 2015. Mr. Hunter qualifies as a financial expert under the applicable rules of the SEC and is an active member of the National Association of Corporate Directors. He holds a Bachelor of Science, magna cum laude, and an MBA with high honors from Boston University. - Donald Hunter自2021年8月与KushCo合并以来一直担任董事，此前曾于2018年2月至合并完成期间担任KushCo的董事。自2007年以来，亨特一直担任Donald Hunter，LLC的负责人，这是一家协助私募股权公司和企业家在2021年之前提升其技术公司价值的咨询机构。他此前曾于2000年至2006年在Harbor Global Company Limited（一家公开上市的投资管理、自然资源和房地产公司）担任首席运营官和首席财务官，并于1988年至2000年在The Pioneer Group，Inc.担任高级管理人员，负责国际初创公司。Hunter的职业生涯始于通用电气公司，曾是该公司审计部门的一员，也是该公司财务管理培训计划的毕业生。自2013年起，Hunter先生担任在纽约证券交易所上市的频率和频谱控制工程与制造公司The LGL Group，Inc.（“LGL”）的董事会成员，还担任LGL审计委员会主席及其提名委员会成员，之前曾在其薪酬委员会任职至2022年12月。此前，Hunter先生于2014年3月至2016年3月期间担任纳斯达克上市的特种制药公司瞻博制药的董事会成员、审计委员会主席和提名委员会成员，并于2014年6月至2015年6月期间担任LICT Corporation的董事会成员，LICT Corporation是一家在电信和多媒体领域拥有子公司的控股公司。亨特先生符合SEC适用规则下的金融专家资格，是美国全国公司董事协会的活跃成员。他以优异成绩获得理学学士学位，并获得波士顿大学荣誉MBA学位。亨特先生超过25年的上市公司经验和公司治理、SEC报告、内部控制、国际运营和并购事务方面的知识促使他被任命为董事。
- Donald Hunter has served as a director since the merger with KhCo in Augt 2021 and previoly served as a director of KhCo from February 2018 until the closing of the merger. Mr. Hunter served as principal at Donald Hunter, LLC, a consulting practice that assists private equity firms and entrepreneurs to enhance the value of their technology companies from 2007 to 2021. He previoly served as Chief Operating Officer and Chief Financial Officer of Harbor Global Company Limited, a publicly traded investment management, natural resces, and real estate company from 2000 through 2006, and as a senior executive at The Pioneer Group, Inc. from 1988 through 2000, with responsibility for international start up companies. Mr. Hunter began his career at the General Electric Company, where he was a member of the corporate audit staff and a graduate of its Financial Management Training Program. From 2013 to 2022, Mr. Hunter served as a member of the board of directors of The LGL Group, Inc. ("LGL"), an NYSE listed frequency and spectrum control engineering and manufacturing company, and also serves as the Chairman of the LGL Audit Committee and a member of its Nominating Committee, and formerly served on its Compensation Committee. Previoly, Mr. Hunter served as a member of the board of directors, Chairman of the Audit Committee and member of the Nominating Committee of Juniper Pharmaceuticals, a Nasdaq listed specialty pharmaceuticals company, from March 2014 through March 2016, and a member of the board of directors of LICT Corporation, a holding company with subsidiaries in telecommunications and multimedia, from June 2014 through June 2015. Mr. Hunter qualifies as a financial expert under the applicable rules of the SEC and is an active member of the National Association of Corporate Directors. He holds a Bachelor of Science, magna cum laude, and an MBA with high honors from Boston University.
- Bruce Linton
-
布鲁斯·林顿目前担任迷幻健康公司Red Light Holland Corp.的顾问和咨询委员会主席、非营利性支持加拿大队项目的加拿大奥林匹克基金会的董事，并担任渥太华医院基金会的执行委员会成员，该基金会是一家支持医疗保健和医学研究的非营利组织。从2022年到2024年，林顿先生曾担任健康和保健公司Melodiol Global Health Ltd.的董事。Linton先生此前还曾在2020-2022年期间担任生命科学风险投资公司ó skare Capital的非执行主席，在2019-2021年期间担任药用生物技术公司Mind Medicine的董事，在2019-2021年期间担任医用大麻技术创新公司Gage Growth Corp的执行主席，在2019-2021年期间担任技术和大麻驱动的SPAC公司Collective Growth Corp.的首席执行官和董事长，在2013-2023年期间担任Martello Technologies Group Inc.的联席主席和前任首席执行官。Linton先生还是Canopy Growth Corporation的创始人、前董事长兼首席执行官，该公司是纽约证券交易所第一家受联邦监管的大麻生产商。Linton先生为董事会带来了在政策驱动行业的公司战略、治理和扩展组织方面的丰富经验。
Bruce Linton currently serves as Advisor and Chairman of the Advisory Committee of Red Light Holland Corp., a psychedelic llness company, Director of Canadian Olympic Foundation, a non profit supporting Team Canada programs, and serves on the Executive Committee of Ottawa Hospital Foundation, a non profit organization support healthcare and medical research. From 2022 until 2024, Mr. Linton previoly served as Director of Melodiol Global Health Ltd., a health and llness company. Mr. Linton also previoly served as the Non Executive Chairman of skare Capital, a life sciences venture capital firm from 2020 2022, as Director of Mind Medicine, a medicinal biotech company from 2019 2021, as Executive Chairman of Gage Growth Corp, a medical cannabis technology innovation company from 2019 2021, as Chief Executive Officer and Chairman of Collective Growth Corp., a technology and cannabis driven SPAC from 2019 2021, and as Co Chairman and former Chief Executive Officer of Martello Technologies Group Inc. from 2013 2023. Mr. Linton is also the Founder and former Chairman and Chief Executive Officer of Canopy Growth Corporation, the first federally regulated cannabis producer on the New York Stock Exchange. Mr. Linton hass to the Board extensive experience in corporate strategy, governance and scaling organizations in policy driven indtries. - 布鲁斯·林顿目前担任迷幻健康公司Red Light Holland Corp.的顾问和咨询委员会主席、非营利性支持加拿大队项目的加拿大奥林匹克基金会的董事，并担任渥太华医院基金会的执行委员会成员，该基金会是一家支持医疗保健和医学研究的非营利组织。从2022年到2024年，林顿先生曾担任健康和保健公司Melodiol Global Health Ltd.的董事。Linton先生此前还曾在2020-2022年期间担任生命科学风险投资公司ó skare Capital的非执行主席，在2019-2021年期间担任药用生物技术公司Mind Medicine的董事，在2019-2021年期间担任医用大麻技术创新公司Gage Growth Corp的执行主席，在2019-2021年期间担任技术和大麻驱动的SPAC公司Collective Growth Corp.的首席执行官和董事长，在2013-2023年期间担任Martello Technologies Group Inc.的联席主席和前任首席执行官。Linton先生还是Canopy Growth Corporation的创始人、前董事长兼首席执行官，该公司是纽约证券交易所第一家受联邦监管的大麻生产商。Linton先生为董事会带来了在政策驱动行业的公司战略、治理和扩展组织方面的丰富经验。
- Bruce Linton currently serves as Advisor and Chairman of the Advisory Committee of Red Light Holland Corp., a psychedelic llness company, Director of Canadian Olympic Foundation, a non profit supporting Team Canada programs, and serves on the Executive Committee of Ottawa Hospital Foundation, a non profit organization support healthcare and medical research. From 2022 until 2024, Mr. Linton previoly served as Director of Melodiol Global Health Ltd., a health and llness company. Mr. Linton also previoly served as the Non Executive Chairman of skare Capital, a life sciences venture capital firm from 2020 2022, as Director of Mind Medicine, a medicinal biotech company from 2019 2021, as Executive Chairman of Gage Growth Corp, a medical cannabis technology innovation company from 2019 2021, as Chief Executive Officer and Chairman of Collective Growth Corp., a technology and cannabis driven SPAC from 2019 2021, and as Co Chairman and former Chief Executive Officer of Martello Technologies Group Inc. from 2013 2023. Mr. Linton is also the Founder and former Chairman and Chief Executive Officer of Canopy Growth Corporation, the first federally regulated cannabis producer on the New York Stock Exchange. Mr. Linton hass to the Board extensive experience in corporate strategy, governance and scaling organizations in policy driven indtries.
- William Levy
-
William Levy，目前担任WP Labs Inc.的首席执行官和董事，WP Labs Inc.是一家消费者和商业软件开发公司，直接监督企业管理、产品开发和业务运营。利维此前与他人共同创立了电竞平台Virgin Gaming、领先的大麻包装消费品公司SLANG WORLDWIDE INC.和面向技术和消费品客户的企业战略和咨询服务公司Frequency Advisors，Inc.。自2020年以来，Levy先生还担任过Frequency Advisors的首席执行官和董事。直到2020年，Levy先生一直担任SLANG WORLDWIDE INC的总裁。Levy先生为董事会带来了在领导力、战略、公司治理和技术方面的丰富经验。
William Levy currently serves as the Chief Executive Officer and Director of WP Labs Inc., a consumer and biness software development company with direct oversight of corporate management, product development, and biness operations. Mr. Levy previoly co founded Virgin Gaming, an esports platform, SLANG WORLDWIDE INC., a leading cannabis consumer packaged goods company and Frequency Advisors, Inc., a corporate strategy and advisory services firm for technology and consumer goods clients. Since 2020, Mr. Levy has also served as the Chief Executive Officer and Director of Frequency Advisors. Until 2020, Mr. Levy served as the President of SLANG WORLDWIDE INC. Mr. Levy hass to the Board extensive experience in leadership, strategy, corporate governance and technology. - William Levy，目前担任WP Labs Inc.的首席执行官和董事，WP Labs Inc.是一家消费者和商业软件开发公司，直接监督企业管理、产品开发和业务运营。利维此前与他人共同创立了电竞平台Virgin Gaming、领先的大麻包装消费品公司SLANG WORLDWIDE INC.和面向技术和消费品客户的企业战略和咨询服务公司Frequency Advisors，Inc.。自2020年以来，Levy先生还担任过Frequency Advisors的首席执行官和董事。直到2020年，Levy先生一直担任SLANG WORLDWIDE INC的总裁。Levy先生为董事会带来了在领导力、战略、公司治理和技术方面的丰富经验。
- William Levy currently serves as the Chief Executive Officer and Director of WP Labs Inc., a consumer and biness software development company with direct oversight of corporate management, product development, and biness operations. Mr. Levy previoly co founded Virgin Gaming, an esports platform, SLANG WORLDWIDE INC., a leading cannabis consumer packaged goods company and Frequency Advisors, Inc., a corporate strategy and advisory services firm for technology and consumer goods clients. Since 2020, Mr. Levy has also served as the Chief Executive Officer and Director of Frequency Advisors. Until 2020, Mr. Levy served as the President of SLANG WORLDWIDE INC. Mr. Levy hass to the Board extensive experience in leadership, strategy, corporate governance and technology.
- Jonathan Hue Fay Ip
-
Jonathan Hue Fay IP是Iterative Law Profession Corporation（“Iterative Law”）的创始人，该公司是一家商业律师事务所，专注于为企业家、初创公司和成长型公司提供实用的商业优先法律服务，他自2020年以来一直担任该职务。叶先生目前还担任LS Retail（Canada）Inc.的董事，该公司是LS Retail的加拿大子公司，是POS和业务管理软件的开发商和供应商。自2021年以来，IP先生还担任Bluefin的总法律顾问，这是一种高性能、非托管交易协议，并担任Divergence Neuro的总法律顾问，该公司是一家神经科技公司，自2020年以来专注于研发改善心理健康的工具。IP先生此前还曾在一家国际商业银行担任法律和企业发展副总裁，并在Bennett Jones LLP和Davies Ward Phillips & Vineberg LLP（后者作为合伙人）的公司/商业、证券、并购和企业融资领域执业。叶先生获得多伦多大学荣誉理学学士学位、皇后大学教育学士学位和奥斯古德霍尔法学院法学学士学位。
Jonathan Hue Fay Ip,is the founder of Iterative Law Profession Corporation ("Iterative Law"), a business law firm focused on delivering practical business-first legal services to entrepreneurs, startups and growth-oriented companies, a role he has held since 2020. Mr. Ip also currently serves as a director of LS Retail (Canada) Inc., the Canadian subsidiary of LS Retail, a developer and provider of POS and business management software. Since 2021, Mr. Ip has also served as General Counsel for Bluefin, a high-performance, non-custodial trading protocol and has served as General Counsel for Divergence Neuro, a neurotech company focused on the research and development of tools to improve mental health since 2020. Mr. Ip has also previously served as Vice President, Legal and Corporate Development at an international merchant bank and practiced in the areas of corporate/commercial, securities, M&A and corporate finance at Bennett Jones LLP and Davies Ward Phillips & Vineberg LLP (the latter as a partner). Mr. Ip received an Honours Bachelor of Science from the University of Toronto, a Bachelor of Education degree from Queen's University and a Bachelor of Laws degree from Osgoode Hall Law School. - Jonathan Hue Fay IP是Iterative Law Profession Corporation（“Iterative Law”）的创始人，该公司是一家商业律师事务所，专注于为企业家、初创公司和成长型公司提供实用的商业优先法律服务，他自2020年以来一直担任该职务。叶先生目前还担任LS Retail（Canada）Inc.的董事，该公司是LS Retail的加拿大子公司，是POS和业务管理软件的开发商和供应商。自2021年以来，IP先生还担任Bluefin的总法律顾问，这是一种高性能、非托管交易协议，并担任Divergence Neuro的总法律顾问，该公司是一家神经科技公司，自2020年以来专注于研发改善心理健康的工具。IP先生此前还曾在一家国际商业银行担任法律和企业发展副总裁，并在Bennett Jones LLP和Davies Ward Phillips & Vineberg LLP（后者作为合伙人）的公司/商业、证券、并购和企业融资领域执业。叶先生获得多伦多大学荣誉理学学士学位、皇后大学教育学士学位和奥斯古德霍尔法学院法学学士学位。
- Jonathan Hue Fay Ip,is the founder of Iterative Law Profession Corporation ("Iterative Law"), a business law firm focused on delivering practical business-first legal services to entrepreneurs, startups and growth-oriented companies, a role he has held since 2020. Mr. Ip also currently serves as a director of LS Retail (Canada) Inc., the Canadian subsidiary of LS Retail, a developer and provider of POS and business management software. Since 2021, Mr. Ip has also served as General Counsel for Bluefin, a high-performance, non-custodial trading protocol and has served as General Counsel for Divergence Neuro, a neurotech company focused on the research and development of tools to improve mental health since 2020. Mr. Ip has also previously served as Vice President, Legal and Corporate Development at an international merchant bank and practiced in the areas of corporate/commercial, securities, M&A and corporate finance at Bennett Jones LLP and Davies Ward Phillips & Vineberg LLP (the latter as a partner). Mr. Ip received an Honours Bachelor of Science from the University of Toronto, a Bachelor of Education degree from Queen's University and a Bachelor of Laws degree from Osgoode Hall Law School.
- Michael C. Howe
-
Michael C. Howe， 2011年7月加入Wireless Ronin Technologies, Inc.董事会。他是Howe Associates， Inc.的负责人，这是一家天使投资和咨询机构，帮助客户获得增长机会，组织效率和企业范围内创新的增强。2010年12月至2011年6月，他曾担任Howe Associates， Inc.的顾问，执行业务规划和战略项目。该实体还向Wireless Ronin Technologies， Inc.提供某些软件开发咨询服务。从2005年6月到2008年6月，他担任MinuteClinic， Inc.的总裁兼首席执行官，这是一家便捷的步入式医疗保健服务提供商。在MinuteClinic任职期间，他设计并执行了公司的全国扩张工作，将公司从2个州的19个医疗保健诊所扩展到25个州的超过525个医疗保健诊所，之后该公司于2006年被CVS Caremark Corporation收购。从1995年到2004年，他在Arby's Inc.担任各种职务，最近的职位是1999年到2004年担任总裁兼首席执行官。1995年之前，Howe先生曾在YUM！品牌公司，海伦柯蒂斯工业公司和宝洁公司。
Michael C. Howe has a proven track record of leading and building successful consumer foced binesses across several different biness sectors including consumer goods, fast food restaurants, SaaS products, and innovative healthcare companies such as MinuteClinic. During his career he has held leadership positions in organizations such as Procter & Gamble, PepsiCo, and Arby's. Michael is one of the f founders of The Good Clinic brand and served as the Chief Executive Officer leading the development of the branding foundation and the initial expansion. His healthcare leadership and expertise in creating innovative consumer foced brands was most effectively demonstrated in his leadership of the MinuteClinic brand, the first consumer / retail foced healthcare brand innovation. Mr. Ho joined MinuteClinic in June 2005 as the brand struggled to define a clear national expansion strategy. At that time the company had established 19 clinics in two markets. Within 15 months Mr. Ho added more than 100 clinics in 13 markets and facilitated the sale of the company to CVS in September 2006, which delivered a nearly sixfold return for investors. He stayed with CVS as CEO of MinuteClinic for 2 additional years leading the national expansion from the original 19 clinics to more than 530. After leaving CVS in September of 2008, Mr. Ho foced on supporting start up and early stage companies in their expansion processes, as an angel investor, board member, and executive leading 11 groups to a successful financial exit. His areas of foc for include branding, marketing, site development, and operational leadership and organizational development. He earned both his accounting and biness degrees from the University of Minnesota, Duluth after serving 4 years in the U.S. Air Force. - Michael C. Howe， 2011年7月加入Wireless Ronin Technologies, Inc.董事会。他是Howe Associates， Inc.的负责人，这是一家天使投资和咨询机构，帮助客户获得增长机会，组织效率和企业范围内创新的增强。2010年12月至2011年6月，他曾担任Howe Associates， Inc.的顾问，执行业务规划和战略项目。该实体还向Wireless Ronin Technologies， Inc.提供某些软件开发咨询服务。从2005年6月到2008年6月，他担任MinuteClinic， Inc.的总裁兼首席执行官，这是一家便捷的步入式医疗保健服务提供商。在MinuteClinic任职期间，他设计并执行了公司的全国扩张工作，将公司从2个州的19个医疗保健诊所扩展到25个州的超过525个医疗保健诊所，之后该公司于2006年被CVS Caremark Corporation收购。从1995年到2004年，他在Arby's Inc.担任各种职务，最近的职位是1999年到2004年担任总裁兼首席执行官。1995年之前，Howe先生曾在YUM！品牌公司，海伦柯蒂斯工业公司和宝洁公司。
- Michael C. Howe has a proven track record of leading and building successful consumer foced binesses across several different biness sectors including consumer goods, fast food restaurants, SaaS products, and innovative healthcare companies such as MinuteClinic. During his career he has held leadership positions in organizations such as Procter & Gamble, PepsiCo, and Arby's. Michael is one of the f founders of The Good Clinic brand and served as the Chief Executive Officer leading the development of the branding foundation and the initial expansion. His healthcare leadership and expertise in creating innovative consumer foced brands was most effectively demonstrated in his leadership of the MinuteClinic brand, the first consumer / retail foced healthcare brand innovation. Mr. Ho joined MinuteClinic in June 2005 as the brand struggled to define a clear national expansion strategy. At that time the company had established 19 clinics in two markets. Within 15 months Mr. Ho added more than 100 clinics in 13 markets and facilitated the sale of the company to CVS in September 2006, which delivered a nearly sixfold return for investors. He stayed with CVS as CEO of MinuteClinic for 2 additional years leading the national expansion from the original 19 clinics to more than 530. After leaving CVS in September of 2008, Mr. Ho foced on supporting start up and early stage companies in their expansion processes, as an angel investor, board member, and executive leading 11 groups to a successful financial exit. His areas of foc for include branding, marketing, site development, and operational leadership and organizational development. He earned both his accounting and biness degrees from the University of Minnesota, Duluth after serving 4 years in the U.S. Air Force.
高管简历
中英对照 | 中文 | 英文- Benjamin Isenberg
Benjamin Isenberg目前担任BSQD Corp.的创始人和负责人，BSQD Corp.是一家专门从事数字资产和加密货币的做市和自营交易公司。在这个职位上，Isenberg先生负责数字资产交易运营的战略方向和监督。他自2022年以来一直担任这一职务。在此之前，Isenberg先生于2021-2024年期间在Tradias GmbH担任交易员，该公司是一家位于德国法兰克福的受BAFIN监管的做市商。在进入数字资产市场之前，Isenberg先生曾在多伦多的M Partners从事投资银行工作，从2019年到2021年，他在那里从事数字资产、技术和采矿方面的工作。
Benjamin Isenberg,currently serves as Founder and Principal of BSQD Corp., a market making and proprietary trading firm specializing in digital assets and cryptocurrencies. In this role, Mr. Isenberg is responsible for the strategic direction and oversight of digital asset trading operations. He has held this position since 2022. Prior to this, Mr. Isenberg served as a Trader at Tradias GmbH, a BAFIN regulated market maker based in Frankfurt, Germany from 2021- 2024. Before entering into the digital asset markets, Mr. Isenberg worked in investment banking at M Partners in Toronto, where he covered digital-assets, technology and mining from 2019-2021.- Benjamin Isenberg目前担任BSQD Corp.的创始人和负责人，BSQD Corp.是一家专门从事数字资产和加密货币的做市和自营交易公司。在这个职位上，Isenberg先生负责数字资产交易运营的战略方向和监督。他自2022年以来一直担任这一职务。在此之前，Isenberg先生于2021-2024年期间在Tradias GmbH担任交易员，该公司是一家位于德国法兰克福的受BAFIN监管的做市商。在进入数字资产市场之前，Isenberg先生曾在多伦多的M Partners从事投资银行工作，从2019年到2021年，他在那里从事数字资产、技术和采矿方面的工作。
- Benjamin Isenberg,currently serves as Founder and Principal of BSQD Corp., a market making and proprietary trading firm specializing in digital assets and cryptocurrencies. In this role, Mr. Isenberg is responsible for the strategic direction and oversight of digital asset trading operations. He has held this position since 2022. Prior to this, Mr. Isenberg served as a Trader at Tradias GmbH, a BAFIN regulated market maker based in Frankfurt, Germany from 2021- 2024. Before entering into the digital asset markets, Mr. Isenberg worked in investment banking at M Partners in Toronto, where he covered digital-assets, technology and mining from 2019-2021.
- Vanessa Guzman Clark
- 暂无中文简介
暂无英文简介 - 暂无中文简介
- 暂无英文简介